Jorge Garbino

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. pmc Atypical infections in tsunami survivors
    Christian Garzoni
    University Hospitals of Geneva, Geneva, Switzerland
    Emerg Infect Dis 11:1591-3. 2005
  2. doi Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infection
    Jorge Garbino
    Division of Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland
    AIDS 22:701-5. 2008
  3. ncbi Impact of enteral versus parenteral nutrition on the incidence of fungal infections: a retrospective study in ICU patients on mechanical ventilation with selective digestive decontamination
    Jorge Garbino
    Division of Infectious Diseases, University of Geneva Hospitals, Geneva, Switzerland
    Clin Nutr 23:705-10. 2004
  4. pmc Impact of positive legionella urinary antigen test on patient management and improvement of antibiotic use
    J Garbino
    Division of Infectious Diseases, Department of Internal Medicine, University of Geneva Hospitals, 1211 Geneva 14, Switzerland
    J Clin Pathol 57:1302-5. 2004
  5. ncbi Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature
    Jorge Garbino
    Division of Infectious Diseases, Department of Internal Medicine, University of Geneva Hospitals, Geneva, Switzerland
    Transpl Int 18:613-8. 2005
  6. ncbi Should we continue using amphotericin B deoxycholate for the treatment of fungal infections? Adverse events and clinical outcomes
    Jorge Garbino
    Division of Infectious Diseases, University Hospitals of Geneva, Switzerland
    Scand J Infect Dis 38:110-3. 2006
  7. doi Respiratory viruses in bronchoalveolar lavage: a hospital-based cohort study in adults
    J Garbino
    University Hospitals of Geneva, Switzerland
    Thorax 64:399-404. 2009
  8. doi Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature
    Jorge Garbino
    Division of Infectious Diseases, Department of Internal Medicine, University of Geneva Hospitals, Geneva, Switzerland
    J Pediatr Hematol Oncol 32:85-7. 2010
  9. ncbi Invasive aspergillosis: is treatment with "inexpensive" amphotericin B cost saving if "expensive" voriconazole is only used on demand?
    Jorge Garbino
    Infectious Disease Division, Unviersity Hospital Geneva, Geneva, Switzerland
    Swiss Med Wkly 136:624-30. 2006
  10. ncbi Use of high-dose liposomal amphotericin B: efficacy and tolerance
    Jorge Garbino
    Division of Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland
    Acta Biomed 77:19-22. 2006

Detail Information

Publications57

  1. pmc Atypical infections in tsunami survivors
    Christian Garzoni
    University Hospitals of Geneva, Geneva, Switzerland
    Emerg Infect Dis 11:1591-3. 2005
    ..Treating these infections is challenging from a clinical and microbiologic point of view...
  2. doi Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infection
    Jorge Garbino
    Division of Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland
    AIDS 22:701-5. 2008
    ..To assess the incidence and epidemiological pattern of respiratory viruses in HIV-infected patients and to evaluate their potential clinical impact...
  3. ncbi Impact of enteral versus parenteral nutrition on the incidence of fungal infections: a retrospective study in ICU patients on mechanical ventilation with selective digestive decontamination
    Jorge Garbino
    Division of Infectious Diseases, University of Geneva Hospitals, Geneva, Switzerland
    Clin Nutr 23:705-10. 2004
    ..This study tests the hypothesis that the incidence of fungal infections is lower in critically ill patients under mechanical ventilation receiving enteral rather than total parenteral nutrition...
  4. pmc Impact of positive legionella urinary antigen test on patient management and improvement of antibiotic use
    J Garbino
    Division of Infectious Diseases, Department of Internal Medicine, University of Geneva Hospitals, 1211 Geneva 14, Switzerland
    J Clin Pathol 57:1302-5. 2004
    ..To assess the incidence of legionella infection over a 27 month period at a large university hospital...
  5. ncbi Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature
    Jorge Garbino
    Division of Infectious Diseases, Department of Internal Medicine, University of Geneva Hospitals, Geneva, Switzerland
    Transpl Int 18:613-8. 2005
    ..We also review previously reported cases of fusarial infection in solid organ transplant recipients...
  6. ncbi Should we continue using amphotericin B deoxycholate for the treatment of fungal infections? Adverse events and clinical outcomes
    Jorge Garbino
    Division of Infectious Diseases, University Hospitals of Geneva, Switzerland
    Scand J Infect Dis 38:110-3. 2006
    ..A retrospective review was undertaken to describe adverse events and clinical outcomes in adult patients with IFI treated with only AmBd as initial therapy...
  7. doi Respiratory viruses in bronchoalveolar lavage: a hospital-based cohort study in adults
    J Garbino
    University Hospitals of Geneva, Switzerland
    Thorax 64:399-404. 2009
    ..A study was performed to investigate the association between positive viral detection and respiratory infection in an at-risk population...
  8. doi Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature
    Jorge Garbino
    Division of Infectious Diseases, Department of Internal Medicine, University of Geneva Hospitals, Geneva, Switzerland
    J Pediatr Hematol Oncol 32:85-7. 2010
    ..Treatment with surgery and liposomal amphotericin B followed by posaconazole successfully treated the infection...
  9. ncbi Invasive aspergillosis: is treatment with "inexpensive" amphotericin B cost saving if "expensive" voriconazole is only used on demand?
    Jorge Garbino
    Infectious Disease Division, Unviersity Hospital Geneva, Geneva, Switzerland
    Swiss Med Wkly 136:624-30. 2006
    ..However, the latter is often used as initial treatment due to lower drug acquisition costs. Therefore we performed a cost-effectiveness analysis...
  10. ncbi Use of high-dose liposomal amphotericin B: efficacy and tolerance
    Jorge Garbino
    Division of Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland
    Acta Biomed 77:19-22. 2006
    ..Based on existing evidence from animal models of invasive fungal infections and the earlyclinical experience, L-AmB used athigher doses for invasive fungal infections is a new treatment option...
  11. ncbi A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections
    J Garbino
    Division of Infectious Diseases, University Hospitals of Geneva, 24 Rue Micheli du Crest, CH 1211 Geneva 14, Switzerland
    Infection 35:161-6. 2007
    ..The aim of this study was to evaluate the efficacy of parenteral cefepime + metronidazole vs imipenem-cilastatin for the treatment of intra-abdominal infections in adult patients...
  12. ncbi Absidia posttraumatic infection: successful treatment with posaconazole
    J Garbino
    Division of Infectious Diseases, University Hospitals of Geneva, 24, Rue Micheli du Crest, CH 1211 Geneva 14, Switzerland
    J Infect 51:e135-8. 2005
    ..In the present study, we describe a patient who had severe traumatic injury with an Absidia infection, who developed intolerance to antifungal treatment with amphotericin B, but responded to posaconazole treatment...
  13. ncbi Arterial mycotic aneurysm rupture following kidney-pancreatic transplantation with exocrine pancreatic drainage into the bladder: an unusual observation
    J Garbino
    Division of Infectious Diseases, University Hospitals of Geneva, 24, Rue Micheli du Crest, 1211 Geneva 14, Switzerland
    Ann Vasc Surg 15:393-5. 2001
    ....
  14. ncbi An unusual cause of vertebral osteomyelitis: Candida species
    Jorge Garbino
    Division of Infectious Diseases, Department of Internal Medicine, University of Geneva Hospitals, Geneva, Switzerland
    Scand J Infect Dis 35:288-91. 2003
    ..Candida species rarely cause spondylodiscitis. During 3 y, 3 cases of vertebral osteomyelitis due to Candida spp. (Candida albicans and Candida tropicalis) were diagnosed, 2 of which were associated with a spinal epidural abscess...
  15. ncbi Fungemia in HIV-infected patients: a 12-year study in a tertiary care hospital
    J Garbino
    Division of Infectious Diseases, University of Geneva Hospitals, Geneva, Switzerland
    AIDS Patient Care STDS 15:407-10. 2001
    ..Fungemias in HIV-infected patients have declined significantly since 1996. This coincides with the introduction of highly active antiretroviral therapy (HAART)...
  16. ncbi Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland
    J Garbino
    Division of Infectious Diseases, Department of Internal Medicine, University Hospitals of Geneva, Geneva, Switzerland
    Int J Infect Dis 6:288-93. 2002
    ..The purpose of this paper is to present the main epidemiologic features of patients with CAP requiring hospitalization in our country...
  17. ncbi Successful treatment of pulmonary invasive aspergillosis with voriconazole in patients who failed conventional therapy
    J Garbino
    Division of Infectious Disease, Dept of Internal Medicine, University Hospital Geneva, 24 Rue Micheli du Crest, CH 1211 Geneva 14, Switzerland
    Infection 31:241-3. 2003
    ..The incidence of fungal infections, including those due to Aspergillosis species has continued to increase in recent years. Invasive aspergillosis remains an important cause of morbidity and mortality, despite therapeutics interventions...
  18. ncbi Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole
    Jorge Garbino
    Division of Infectious Diseases, University of Geneva Hospitals, Switzerland
    Scand J Infect Dis 34:701-3. 2002
    ..lilacinus endophthalmitis who was treated with the new triazole, voriconazole, for 4 months, with a good clinical evolution. This treatment appears to be a valuable new therapeutic option but requires further clinical confirmation...
  19. ncbi Immunomodulatory therapy in yeast infections
    Jorge Garbino
    University Hospitals of Geneva, Infectious Diseases Division Clinical Research, 24 Rue Micheli du Crest, 1211 Geneva 14, Switzerland
    Expert Rev Anti Infect Ther 5:129-40. 2007
    ..Further preclinical and clinical studies, as well as improving our understanding of immune system functions and dysfunctions, remain a future challenge...
  20. ncbi Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units
    Jutta M Loeffler
    Division of Infectious Diseases, Department of Internal Medicine, University Hospital of Geneva, Geneva, Switzerland
    Scand J Infect Dis 35:843-50. 2003
    ..for cephalosporin, in coagulase-negative staphylococci for gentamicin and in Streptococcus pneumoniae for penicillin...
  21. ncbi Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact
    Jorge Garbino
    Department of Medicine, Division of Infectious Diseases, Central Laboratory of Virology, University Hospitals of Geneva, 24 Rue Micheli du Crest, 1211 Geneva 14, Switzerland
    Am J Respir Crit Care Med 170:1197-203. 2004
    ..These viruses were associated with high morbidity, particularly in lung transplant recipients...
  22. ncbi Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000
    Oscar Marchetti
    Infectious Diseases Service, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    Clin Infect Dis 38:311-20. 2004
    ..krusei remained rare (2%). Fluconazole consumption increased significantly (P<.001). Despite increasing high-risk activities, the incidence of candidemia remained unchanged, and no shift to resistant species occurred...
  23. ncbi Chronic rhinoviral infection in lung transplant recipients
    Laurent Kaiser
    Central Laboratory of Virology, Division of Infectious Diseases, Department of Internal Medicine, University Hospitals of Geneva, Switzerland
    Am J Respir Crit Care Med 174:1392-9. 2006
    ..Lung transplant recipients are particularly at risk of complications from rhinovirus, the most frequent respiratory virus circulating in the community...
  24. ncbi Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis
    Stephan Harbarth
    Divisions of Infectious Diseases, University of Geneva Hospitals, Geneva, Switzerland
    Am J Med 115:529-35. 2003
    ..To examine the effect of inappropriate initial antimicrobial therapy on the prognosis of patients with sepsis who were enrolled in a clinical trial of an immunomodulating agent conducted in 108 hospitals in North America and Europe...
  25. ncbi Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital
    Jorge Garbino
    Department of Internal Medicine, University of Geneva Hospital, Switzerland
    Medicine (Baltimore) 81:425-33. 2002
    ..Factors independently associated with higher mortality were patient age greater than 65 years, intensive care unit admission, and underlying cancer...
  26. ncbi Invasive candidiasis: comparison of management choices by infectious disease and critical care specialists
    Philippe Eggimann
    Infection Control Program, University of Geneva Hospitals, 24 Rue Micheli du Crest, 1211, Geneva 14, Switzerland
    Intensive Care Med 31:1514-21. 2005
    ..To compare the management of invasive candidiasis between infectious disease and critical care specialists...
  27. ncbi A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection
    Jorge Garbino
    Division of Infectious Diseases, University Hospitals of Geneva, Geneva, 1211, Switzerland
    Clin Infect Dis 43:1009-15. 2006
    ..Their impact as a cause of respiratory tract disease in adults at risk for complications needs to be established...
  28. doi Short parenteral antibiotic treatment for adult septic arthritis after successful drainage
    Ilker Uckay
    Orthopedic Surgery Service, Geneva University Hospitals and Faculty of Medicine, University of Geneva, 4, rue Gabrielle Perret Gentil, 1211 Geneva 14, Switzerland
    Int J Infect Dis 17:e199-205. 2013
    ..To assess the risk factors for recurrence of septic arthritis with an emphasis on the duration of antibiotic treatment, to gather data for a prospective study on an optimized antibiotic treatment in adults with septic arthritis...
  29. ncbi Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination
    Jorge Garbino
    Division of Infectious Diseases, Department of Internal Medicine, University of Geneva Hospitals, 1211 Geneva 14, Switzerland
    Intensive Care Med 28:1708-17. 2002
    ..We assessed the effectiveness of adding fluconazole to a selective digestive decontamination regimen to prevent candidal infections...
  30. ncbi Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
    Philippe Eggimann
    Medical Clinic II, the Medical Intensive Care Unit and the Infection Control Programme, Department of Internal Medicine, University of Geneva Hospitals, Geneva, Switzerland
    Lancet Infect Dis 3:685-702. 2003
    ..Management of invasive candidiasis in these patients will be addressed in the December issue of The Lancet Infectious Diseases...
  31. ncbi Respiratory viruses and severe lower respiratory tract complications in hospitalized patients
    Jorge Garbino
    Division of Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland
    Chest 125:1033-9. 2004
    ..We report the clinical impact of acute lower respiratory tract viral infections in hospitalized patients...
  32. ncbi Management of Candida species infections in critically ill patients
    Philippe Eggimann
    Medical Clinic II and Intensive Care Unit, and the Infection Control Programme, Department of Internal Medicine, University of Geneva Hospitals, Geneva, Switzerland
    Lancet Infect Dis 3:772-85. 2003
    ..Among critically ill patients, azole prophylaxis is effective and is not associated with acquisition of resistance; it must be restricted to highly selected groups of patients at high risk only...
  33. ncbi Infection and rejection in liver transplant patients: a 10-year Swiss single-centre experience
    Jorge Garbino
    Division of Infectious Diseases, University Hospitals of Geneva, 1211 Geneva 14, Switzerland
    Swiss Med Wkly 135:587-93. 2005
    ..Rejection treatment may be associated with an increased rate of infectious complications. The aim of this study was to determine the relationship between rejection, rejection therapy and the risk of associated infections...
  34. pmc Recurrent bacteremia with Helicobacter cinaedi: case report and review of the literature
    Ilker Uckay
    Division of Infectious Diseases, Department of Medicine, University Hospital of Geneva, Switzerland
    BMC Infect Dis 6:86. 2006
    ..Helicobacter cinaedi is a rare pathogen in humans, occurring mostly in immuno-compromised patients, with a high potential for recurrence. We describe a case of a patient with lymphoma hospitalized for chemotherapy...
  35. doi Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors
    Juan Ambrosioni
    Division of Infectious Diseases, University of Geneva Hospitals and Faculty of Medicine, 4 rue Gabrielle Perret Gentil, Geneva 14, Switzerland
    Int J Infect Dis 14:e100-3. 2010
    ..Presented herein is our investigation of the epidemiological factors associated with an increasing incidence of the disease at the University of Geneva Hospitals, Geneva, Switzerland, over the past five years...
  36. pmc Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study
    G Zanetti
    Division of Infectious Diseases, Department of Microbiology, and Intensive Care Unit, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    Antimicrob Agents Chemother 47:3442-7. 2003
    ..aeruginosa. Selection of a single agent for therapy of nosocomial pneumonia should be guided by local resistance patterns...
  37. ncbi Caspofungin in the treatment of oropharyngeal candidiasis
    J Garbino
    Division of Infectious Diseases, University of Geneva Hospitals, Geneva, Switzerland
    Int J Clin Pract 57:143-4. 2003
    ..Therapy with caspofungin was then initiated (70 mg loading dose, followed by 50 mg/day). The patient responded favourably to caspofungin, with complete resolution of signs and symptoms...
  38. ncbi Severe Mycoplasma hominis infections in two renal transplant patients
    P Rohner
    Service des Maladies Infectieuses, Hopitaux Universitaire de Geneve, 1211 Geneve 14, Switzerland
    Eur J Clin Microbiol Infect Dis 23:203-4. 2004
    ..Effective treatment with doxycycline was administered only after definitive identification of Mycoplasma hominis was achieved. For this identification, the new genetic amplification-sequencing method was invaluable...
  39. ncbi Lack of effect of combination antibiotic therapy on mortality in patients with pneumococcal sepsis
    S Harbarth
    Division of Infectious Diseases, University of Geneva Hospitals, Geneva, Switzerland
    Eur J Clin Microbiol Infect Dis 24:688-90. 2005
    ..Overall, in contrast to recently published reports, these results suggest that combination antibiotic therapy does not decrease mortality after severe pneumococcal sepsis...
  40. ncbi Group A beta-hemolytic streptococcus meningitis: clinical and microbiological features of nine cases
    R Sommer
    Division of Infectious Diseases, University Hospital of Geneva, Switzerland
    Clin Infect Dis 29:929-31. 1999
    ..Our observations suggest that GAS meningitis in adults is associated with neurosurgical conditions and/or an upper respiratory tract infection...
  41. doi Upper and lower respiratory tract viral infections and acute graft rejection in lung transplant recipients
    P M Soccal
    Division of Pulmonary Medicine, University Hospitals of Geneva, Geneva
    Clin Infect Dis 51:163-70. 2010
    ....
  42. pmc The safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of Gram-positive osteoarticular infections
    Kheeldass Jugun
    Orthopaedic Surgery Service, Geneva University Hospital and Medical School, Geneva, Switzerland
    Int Orthop 37:1375-80. 2013
    ..The aim of this study was to evaluate the safety and efficacy of a combined regimen of high-dose daptomycin and rifampicin, in patients with various types of Gram-positive osteoarticular infections...
  43. pmc Secular trends of nocardia infection over 15 years in a tertiary care hospital
    R Matulionyte
    Division of Infectious Diseases, Department of Internal Medicine, University of Geneva Hospitals, 1211Geneva, Switzerland
    J Clin Pathol 57:807-12. 2004
    ..To assess the incidence of nocardia infection over 15 years in a tertiary care hospital...
  44. doi Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection
    O Lebeau
    Department of Medicine, Hematology Division, University Hospital Geneva, Geneva, Switzerland
    Transpl Infect Dis 12:269-72. 2010
    ..New combination antifungal therapies might sufficiently control disseminated zygomycosis to allow allo-HSCT to be performed, assuring life-saving immune recovery. Surgery appears to be necessary for definite cure of these infections...
  45. ncbi Anti-inflammatory response after infusion of p55 soluble tumor necrosis factor receptor fusion protein for severe sepsis
    Vincent L Butty
    Department of Anesthesiology, Pharmacology and Surgical Intensive Care, Geneva University Hospital, 1211 Geneva 14, Switzerland
    Eur Cytokine Netw 14:15-9. 2003
    ..To investigate the effects of Lenercept , a recombinant soluble TNF receptor p55 fused to an immunoglobulin heavy chain IgG1, on the balance of pro- and anti-inflammatory mediators in sepsis...
  46. ncbi Candida parapsilosis endocarditis: a comparative review of the literature
    C Garzoni
    Division of Infectious Diseases, University Hospitals of Geneva, 24 Rue Micheli du Crest, Geneva 14, Switzerland
    Eur J Clin Microbiol Infect Dis 26:915-26. 2007
    ..Few patients received the newer antifungal agents, and it would appear that more experience is required for their use in the treatment of C. parapsilosis endocarditis...
  47. ncbi Disseminated histoplasmosis in an HIV-infected patient discovered by routine blood smear staining
    R Matulionyte
    Division of Infectious Diseases, University of Geneva Hospitals, 24, Rue Micheli du Crest, 1211 Geneva 14, Switzerland
    Eur J Clin Microbiol Infect Dis 24:361-3. 2005
  48. doi Nocardiosis: updated clinical review and experience at a tertiary center
    J Ambrosioni
    Division of Infectious Diseases, Faculty of Medicine, University Hospitals of Geneva, 4 rue Gabrielle Perret Gentil, 1211 Geneva 14, Switzerland
    Infection 38:89-97. 2010
    ..We report the epidemiologic characteristics of Nocardia spp. observed in our institution and discuss the risk factors, clinical features, diagnosis, and management of the disease...
  49. doi Invasive fusariosis with prolonged fungemia in a patient with acute lymphoblastic leukemia: case report and review of the literature
    M Jossi
    Infectious Diseases Division, University Hospitals of Geneva, 24 Rue Micheli du Crest, Geneva 14, Switzerland
    Int J Infect Dis 14:e354-6. 2010
    ..A review of the literature for Fusariumspp fungemia was carried out...
  50. ncbi Oral nystatin as antifungal prophylaxis in critically ill patients: an old SDD tool to be renewed?
    Philippe Eggimann
    Intensive Care Med 31:1466-8. 2005
  51. ncbi Treatment options of invasive fungal infections in adults
    Ursula Fluckiger
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, Basel, Switzerland
    Swiss Med Wkly 136:447-63. 2006
    ..Amphotericin B deoxycholate is recommended as initial therapy for the empirical therapy in patients with neutropenia and persistent fever with close monitoring of adverse events...
  52. ncbi A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis
    Jan Pachl
    Charles University, Prague, Czech Republic
    Clin Infect Dis 42:1404-13. 2006
    ..Mycograb (NeuTec Pharma) is a human recombinant monoclonal antibody against heat shock protein 90 that, in laboratory studies, was revealed to have synergy with amphotericin B against a broad spectrum of Candida species...
  53. ncbi Unusual pathogens and multidrug-resistant bacteria in tsunami survivors
    Jorge Garbino
    Clin Infect Dis 42:889-90; author reply 890-1. 2006
  54. ncbi New drugs, old drugs - dear drugs, cheap drugs
    Bernard Hirschel
    Swiss Med Wkly 132:301-2. 2002
  55. doi Cladophialophora bantiana: a rare cause of fungal brain abscess. Clinical aspects and new therapeutic options
    Christian Garzoni
    Infectious Diseases Division, University Hospital of Bern, Bern
    Med Mycol 46:481-6. 2008
    ..We discuss clinical, microbiological and practical pharmacological aspects and review current and evolving treatment options...
  56. ncbi Is anti-tumor necrosis factor therapy associated with increased mortality in patients with severe sepsis caused by pneumonia?
    Stephan Harbarth
    J Infect Dis 189:1743. 2004
  57. ncbi Long-term risk of atypical fungal infection after near-drowning episodes
    Christian Garzoni
    Pediatrics 119:417; author reply 417-8. 2007